Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  ObesityType 2 DiabetesIssue 581Genetics of Diabetes

NIH Findings Have Potential to Curb Obesity and Type 2 Diabetes

Discovery makes white fat mimic energy-burning brown fat, muscle....

Advertisement

Scientists at the National Institutes of Health have uncovered a pathway in mice that allows white fat -- a contributor to obesity and type 2 diabetes -- to burn calories in a way that's normally found in brown fat and muscle. 

White fat is used to store calories. However, too much white fat (obesity) increases the risk of type 2 diabetes and other diseases. Brown fat generates heat to maintain body temperature and, like muscle, has lots of iron-containing, calorie-burning mitochondria in its cells. Changing white fat into brown fat or muscle is a potential new approach to treating obesity and type 2 diabetes, although the research is a long way from being applicable to people.

Sushil Rane, Ph.D., a researcher at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases and the paper's senior author, said that the findings were exciting and unexpected. "We weren't looking to have white fat acquire the properties of brown fat, but that's what we found, with the fat getting browner from increased mitochondria and displaying genes typically expressed in muscle. It was a striking difference.

"Efforts to reduce obesity by dieting are mostly unsuccessful in the long term, so finding ways to prevent excess fat storage is an urgent medical need," Rane said. "Our discovery that white fat can be reduced by partially transforming it to brown fat and muscle opens up new avenues to combat the obesity epidemic."

Researchers made their discovery in mice by reducing the actions of a protein called TGF-beta in two ways: through genetic engineering and using an antibody -- a different protein that finds and blocks the TGF-beta protein. The TGF-beta proteins determine the capacity of cells to grow and function normally. Without the TGF-beta actions, the researchers saw that the mice's white fat was getting browner with more mitochondria. The increased metabolic activity due to the mitochondria led to burning calories, thus lessening obesity.

"The default function of white fat is to store energy. This discovery identifies a potential way for it to burn energy instead," said Marc Reitman, M.D., Ph.D., chief of the NIDDK Diabetes, Endocrinology, and Obesity Branch.

The TGF-beta blocking antibody is also being tested as a cancer treatment in people through a trial at the National Cancer Institute. Due to the potential side effects of the antibody, including compromising the immune system, it has not been tested or proven for treatment of human obesity or type 2 diabetes. The researchers next plan to design a more targeted approach to partially transform white fat of mice into the brown fat or muscle-like state without compromising the immune system.

"So many great discoveries are the result of hard work and an openness to being surprised by findings, and to follow where those surprises lead," said NIDDK Director Griffin P. Rodgers, M.D. "If continuing research supports current findings, this discovery has the potential to improve the treatment of obesity and the prevention of type 2 diabetes."

"Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling" was published in Cell Metabolism online on July 5, 2011 (http://www.cell.com/cell-metabolism/abstract/S1550-4131(11)00215-4).

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 08 July, 2011 and appeared in  ObesityType 2 DiabetesIssue 581Genetics of Diabetes

Past five issues: Diabetes Clinical Mastery Series Issue 220 | Special Edition Best of 2014 | Issue 760 | Diabetes Clinical Mastery Series Issue 219 | SGLT-2 Inhibitors Special Edition December 2014 |


Cast Your Vote
For your prediabetes patients who can't lower their blood glucose with lifestyle changes, do you prescribe GLP-1s or SGLT-2s?
CME/CE of the Week
Category: Nutrition
CE Credits: .5
Search Articles On Diabetes In Control